PUBLISHER: The Business Research Company | PRODUCT CODE: 1455259
PUBLISHER: The Business Research Company | PRODUCT CODE: 1455259
Intrauterine devices are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices offer a highly effective and long-lasting method of birth control. Their mechanism involves altering the uterine environment to make it less favorable for sperm to fertilize an egg and, in some cases, affecting the uterine lining to inhibit implantation.
The main types of intrauterine devices include hormonal intrauterine devices and copper intrauterine devices. Hormonal intrauterine devices, often referred to as hormonal IUDs, are contraceptive devices inserted into the uterus for pregnancy prevention. These devices cater to various age groups, such as 15-24 years, 25-34 years, 35-44 years, and those above 44 years. End users of these devices include hospitals, gynecology clinics, community healthcare, and others.
The intrauterine devices market research report is one of a series of new reports from The Business Research Company that provides intrauterine devices market statistics, including intrauterine devices industry global market size, regional shares, competitors with intrauterine devices market share, detailed intrauterine devices market segments, market trends and opportunities, and any further data you may need to thrive in the intrauterine devices industry. This intrauterine devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The intrauterine devices market size has grown strongly in recent years. It will grow from $3.75 billion in 2023 to $3.96 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth observed in the historical period can be attributed to several factors, including family planning initiatives, the empowerment of women, the promotion of long-acting reversible contraception (LARC), the high contraceptive efficacy of intrauterine devices, their cost-effectiveness, the reduction of side effects, and advocacy by healthcare professionals.
The intrauterine devices market size is expected to see steady growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The anticipated growth in the forecast period can be attributed to various factors, including increasing awareness and education, global health initiatives, a shift towards non-hormonal contraceptive options, expanding access to healthcare, the promotion of personalized contraceptive choices, the provision of youth-friendly reproductive services, and integration with primary care services. Major trends expected in the forecast period include the development of frameless IUDs, innovations in biodegradable IUDs, enhancements in user-friendly insertion systems, the integration of contraceptive counseling services, and exploration of non-contraceptive health benefits.
The anticipated rise in the number of unplanned pregnancies is poised to drive the growth of the intrauterine devices market in the coming years. Unplanned pregnancies, characterized as pregnancies that are either unwanted or not intended, occur when individuals do not desire additional children. Intrauterine devices (IUDs) emerge as a highly efficient method of birth control, working by altering the uterine environment to make it less conducive for sperm to fertilize an egg. For instance, data from the United Nations Population Fund in March 2022 highlighted that there are 121 million unintended pregnancies globally each year. Notably, Afghanistan is expected to experience 4.8 million unintended pregnancies by the year 2025. Hence, the increasing prevalence of unplanned pregnancies is a significant driver for the growth of the intrauterine devices market.
The growing number of women in the workforce is also expected to contribute to the expansion of the intrauterine devices market. The term 'women in the workforce' refers to the active participation of women in paid employment across diverse industries and professions. IUDs present working women with a low-maintenance and highly effective contraceptive option, offering long-term protection against unintended pregnancies. For instance, data from the Office for National Statistics in December 2023 indicated that the employment rate for women aged 16 to 64 was 71.9% in 2021, experiencing a slight increase to 72.2% in 2022. Therefore, the rising number of women in the workforce is a driving force behind the growth of the intrauterine devices market.
The expected limited awareness and acceptance of intrauterine devices (IUDs) are likely to impede the growth of the intrauterine devices market in the future. The constrained awareness and acceptance of IUDs have hindered their widespread adoption as a highly effective and reversible contraceptive method, restricting broader reproductive health choices for women. For example, data from NHS Digital in September 2023, a UK-based government agency, revealed that in 2021/22, 55% of females accessing contraception through sexual and reproductive health services utilized Long-Acting Reversible Contraceptives (LARCs), experiencing a 1% decrease from the previous year. Among LARCs, implants were the preferred choice for 22%, followed by intrauterine systems at 16% and intrauterine devices at 10%. Consequently, the limited awareness and acceptance of intrauterine devices are posing a constraint to the growth of the intrauterine devices market.
Prominent companies in the intrauterine devices market are actively involved in developing innovative products, such as IUB Ballerine, to offer women a more effective and convenient form of birth control. IUB Ballerine represents a hormone-free, long-lasting reversible contraceptive made of a flexible nickel/titanium alloy frame with copper beads. These copper beads release copper ions into the uterus, creating an environment hostile to sperm, thereby preventing pregnancy. For instance, in December 2022, Consilient Health Ltd., a UK-based pharmaceutical company, introduced IUB Ballerine, a next-generation intrauterine device designed to be spherical, comfortable, and easy to use. This innovative IUD features a unique three-dimensional ball-such as structure composed of copper beads on a flexible Nitinol frame, minimizing the risk of expulsion and fundal perforation during insertion. It represents a significant advancement in intrauterine contraception, offering improved safety and ease of use over traditional methods.
In December 2022, CooperSurgical Inc., a US-based medical equipment company specializing in manufacturing intrauterine devices (IUDs), entered into a partnership with Ostro, a US-based healthcare technology company. The collaboration between these two companies is geared towards boosting awareness of Paragard as a safe and effective form of contraception. Additionally, the partnership aims to offer women comprehensive information about the various types of IUDs available, with the overarching goal of reducing the stigma associated with IUDs and promoting awareness about pregnancy prevention. This collaborative effort underscores a commitment to advancing reproductive health and ensuring that women have access to accurate information regarding contraceptive options, particularly focusing on the safety and effectiveness of Paragard.
Major companies operating in the intrauterine devices market report are Cardinal Health Inc., Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Perrigo Company plc., CooperSurgical Inc., BIOTRONIK Inc., HLL Lifecare Limited, ANI Pharmaceuticals, Actavis GmbH, DKT International Inc., Nipro Medical Corporation, Pfm medical Inc., Besins HealthCare Limited, Pregna International Limited, SCITECH Medical Inc., Viatris Inc., Medicines360, Afaxys Inc., Access Vascular Inc., OCON Medical Ltd., Agile Therapeutics Inc., SMB Corporation of India, Eurogine S.L.
North America was the largest region in the intrauterine devices market in 2023. The regions covered in the intrauterine devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the intrauterine device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The intrauterine device market consists of sales of T-shaped frames, frameless IUDs, insertion devices, IUD removal kits, and monofilament strings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Intrauterine Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on intrauterine devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for intrauterine devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intrauterine devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of covid 19 on supply chains and consumption patterns.